Latest Insider Transactions at Hca Healthcare, Inc. (HCA)
This section provides a real-time view of insider transactions for Hca Healthcare, Inc. (HCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HCA Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HCA Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,750
+43.69%
|
$1,581,750
$37.18 P/Share
|
|
Nov 12
2021
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Indirect |
4,000
+50.0%
|
-
|
|
Nov 12
2021
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Direct |
4,000
-23.7%
|
-
|
|
Nov 11
2021
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Direct |
4,000
+19.16%
|
-
|
|
Nov 11
2021
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Indirect |
4,000
-6.25%
|
-
|
|
Nov 11
2021
|
Jon M Foster EVP and COO |
SELL
Open market or private sale
|
Direct |
16,294
-83.73%
|
$3,943,148
$242.05 P/Share
|
|
Nov 10
2021
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Open market or private sale
|
Direct |
2,052
-31.2%
|
$504,792
$246.23 P/Share
|
|
Nov 10
2021
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Open market or private sale
|
Direct |
8,252
-18.19%
|
$2,029,992
$246.25 P/Share
|
|
Nov 09
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
3,364
-100.0%
|
$837,636
$249.61 P/Share
|
|
Nov 09
2021
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,081
-51.18%
|
$4,201,926
$246.14 P/Share
|
|
Nov 09
2021
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,375
+50.0%
|
$1,568,625
$47.97 P/Share
|
|
Nov 08
2021
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
6,748
-12.95%
|
$1,666,756
$247.63 P/Share
|
|
Nov 08
2021
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.35%
|
$330,000
$22.95 P/Share
|
|
Nov 08
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,986
-24.95%
|
$1,478,542
$247.63 P/Share
|
|
Nov 08
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
8,095
+15.2%
|
$1,149,490
$142.15 P/Share
|
|
Nov 05
2021
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,163
-43.96%
|
$1,528,424
$248.27 P/Share
|
|
Nov 05
2021
|
Jennifer Berres SVP & Chief Human Res. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,640
+32.91%
|
$798,000
$75.77 P/Share
|
|
Nov 05
2021
|
Christopher F. Wyatt SVP & Controller |
SELL
Open market or private sale
|
Direct |
2,100
-7.02%
|
$529,200
$252.94 P/Share
|
|
Nov 04
2021
|
Bill B Rutherford CFO and EVP |
SELL
Open market or private sale
|
Direct |
20,647
-26.25%
|
$5,161,750
$250.0 P/Share
|
|
Nov 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
3,815
-30.06%
|
$953,750
$250.48 P/Share
|
|
Nov 03
2021
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
200
-0.34%
|
-
|
|
Nov 03
2021
|
Bill B Rutherford CFO and EVP |
SELL
Open market or private sale
|
Direct |
9,353
-10.63%
|
$2,338,250
$250.0 P/Share
|
|
Nov 03
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,324
-56.24%
|
$1,081,000
$250.0 P/Share
|
|
Nov 03
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,688
+50.0%
|
$530,472
$69.58 P/Share
|
|
Nov 02
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,510
-26.22%
|
$1,118,480
$248.44 P/Share
|
|
Nov 02
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,325
+21.97%
|
$482,850
$58.47 P/Share
|
|
Nov 02
2021
|
Samuel N Hazen CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.58%
|
$12,550,000
$251.75 P/Share
|
|
Oct 29
2021
|
Samuel N Hazen CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,790
-17.23%
|
$19,447,500
$250.46 P/Share
|
|
Oct 29
2021
|
Samuel N Hazen CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
152,625
+25.27%
|
$7,173,375
$47.97 P/Share
|
|
Oct 29
2021
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
40,073
-31.29%
|
$10,018,250
$250.46 P/Share
|
|
Oct 29
2021
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
78,625
+38.04%
|
$3,695,375
$47.97 P/Share
|
|
Oct 29
2021
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
3,087
-9.35%
|
$771,750
$250.46 P/Share
|
|
Oct 29
2021
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,260
+13.75%
|
$415,540
$79.8 P/Share
|
|
Oct 27
2021
|
Charles J Hall Group President |
SELL
Bona fide gift
|
Direct |
4,170
-2.14%
|
-
|
|
Sep 01
2021
|
Hugh F Johnston Director |
BUY
Grant, award, or other acquisition
|
Direct |
455
+49.46%
|
-
|
|
Aug 05
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
4,018
-100.0%
|
$1,004,500
$250.12 P/Share
|
|
Aug 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
2,500
-12.25%
|
$627,500
$251.91 P/Share
|
|
Aug 03
2021
|
A Bruce Moore Jr Group President - Service Line |
SELL
Payment of exercise price or tax liability
|
Direct |
18,093
-12.93%
|
$4,577,529
$253.51 P/Share
|
|
Aug 03
2021
|
A Bruce Moore Jr Group President - Service Line |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+21.14%
|
$1,387,500
$37.18 P/Share
|
|
Aug 03
2021
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
6,000
-1.5%
|
$1,512,000
$252.94 P/Share
|
|
Aug 02
2021
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
3,000
-1.47%
|
$750,000
$250.94 P/Share
|
|
Aug 02
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Open market or private sale
|
Indirect |
40,000
-35.26%
|
$10,000,000
$250.01 P/Share
|
|
Aug 02
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
409
-9.24%
|
$101,841
$249.57 P/Share
|
|
Jul 30
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
2,900
-39.58%
|
$722,100
$249.43 P/Share
|
|
Jul 29
2021
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
200
-2.66%
|
$49,800
$249.36 P/Share
|
|
Jul 28
2021
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
200
-0.4%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Indirect |
23,268
+50.0%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Direct |
20,000
-90.56%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Direct |
20,000
+26.21%
|
-
|
|
Jul 28
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Indirect |
23,268
-65.21%
|
-
|